Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

August 01, 2006 (Vol. 26, No. 14)

Case Study: Vaccine Production Facility Built in 11 Months

Combining Opposing Requirements for Aseptic Production and the Regulations Covering Biosafety

  • Aside from being established in only eleven months, Bavarian Nordic (www.bavarian-nordic.com) views its new vaccine facility as unique because its design and technology combine the opposing requirements for aseptic production and biosafety regulations. The cGMP and biocontainment facility produces 40 million doses or more a year of smallpox vaccine ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.